By 2024, the Lloyd's A&H market had entered a hardening cycle: premium rates increasing across group PMI, group IP and travel lines in response to sustained claims inflation (medical 8–10% p.a. UK EST), mental health claims frequency, long-COVID duration uncertainty and rebuilding margins after COVID losses. Parametric travel products and embedded insurance (travel add-ons through credit cards, banks) continued rapid growth. The market debate on pandemic exclusion permanence versus future coverage frameworks remained unresolved.